loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

Approved Drug Products containing 208026 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 BOEHRINGER INGELHEIM (2)

filter

01 TABLET, EXTENDED RELEASE;ORAL (2)

filter

01 RX (2)

filter

01 JENTADUETO XR (2)

filter

01 Yes (2)

URL Supplier Web Content
TABLET, EXTENDED R...
2.5MG;1GM
2016-05-27
208026
JENTADUETO XR
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, EXTENDED R...
5MG;1GM
2016-05-27
208026
JENTADUETO XR
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 208026

Looking for FDA Orange Book APPLICATION 208026 2

19

Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LINAGLIPTIN; METFORMIN HYDROCHLORIDE, with a corresponding application number 208026.

Regulatory Information RX

With a dosage strength 2.5MG;1GM

Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

Reference Listed Drug Yes

Approved since 2016-05-27

18

Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LINAGLIPTIN; METFORMIN HYDROCHLORIDE, with a corresponding application number 208026.

Regulatory Information RX

With a dosage strength 5MG;1GM

Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

Reference Listed Drug Yes

Approved since 2016-05-27

Post Enquiry
POST ENQUIRY